EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Current and emerging treatment approaches for hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer

Komal Jhaveri, Frederik Marmé

Cancer Treatment Reviews · 2024-02 · 123 · 102670

DOI: 10.1016/j.ctrv.2023.102670 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Treatment Reviews, 2024-02. Verfasst von Komal Jhaveri und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York, N…. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Gilead Sciences Inc.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsHumansFemaleQuality of LifePhosphatidylinositol 3-KinasesAntineoplastic Agents, HormonalErb-b2 Receptor Tyrosine Kinases

Stichwörter der Autor:innen

Antibody-drug conjugateEndocrine resistanceHormone receptor-positiveMetastatic breast cancerSacituzumab govitecanTrastuzumab deruxtecan

Substanzen

Phosphatidylinositol 3-KinasesAntineoplastic Agents, HormonalErb-b2 Receptor Tyrosine KinasesERBB2 protein, human

Autor:innen und Institutionen

  • Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York, NY, USA. Electronic address: jhaverik@mskcc.org.
  • Gynecological Oncology Section, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.

Förderung

  • Gilead Sciences Inc

Zitieren

APA

Jhaveri, K., & Marmé, F. (2024). Current and emerging treatment approaches for hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer. Cancer Treatment Reviews, 123, 102670. https://doi.org/10.1016/j.ctrv.2023.102670

Vancouver

Jhaveri K, Marmé F. Current and emerging treatment approaches for hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer. Cancer Treatment Reviews. 2024;123:102670. doi:10.1016/j.ctrv.2023.102670

BibTeX
@article{Jhaveri2024,
  author = {Jhaveri, Komal and Marmé, Frederik},
  title = {Current and emerging treatment approaches for hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer},
  journal = {Cancer Treatment Reviews},
  year = {2024},
  volume = {123},
  pages = {102670},
  doi = {10.1016/j.ctrv.2023.102670}
}
Kostenlos starten →